HOLLIE CLEVELAND: Open Payments
NPI 1720790603 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,562 in 90 payments from 19 companies in 2025. Trend: 2023 $962 · 2024 $1,617 · 2025 $1,562
Food & beverage: $1,562
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $259 |
| AstraZeneca Pharmaceuticals LP | 11 | $187 |
| Lilly USA, LLC | 13 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $124 |
| PFIZER INC. | 7 | $113 |
| Amgen Inc. | 6 | $104 |
| Novo Nordisk Inc | 6 | $84 |
| Vanda Pharmaceuticals Inc. | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| GlaxoSmithKline, LLC. | 4 | $67 |
Products named: MOUNJARO, REXULTI, Kerendia, NURTEC ODT, AIRSUPRA, Repatha, QULIPTA, FANAPT.
Industry payments across AL — which companies pay providers there.
